IR情報

2019/08/15~2020/01/15

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2020
01/154,4194,4194,3824,399-0.2%2,701,7006兆9343億+0.39%
01/1420:00 事業変革の進捗と優先事項の概要について第38回J.P.モルガン・ヘルスケア・カンファレンスにて発表
01/144,4354,4354,3804,408+0.66%3,567,8006兆9485億+0.55%
01/104,3484,3794,3404,379+0.85%2,663,5006兆9028億-0.16%
01/094,3184,3594,3104,342+2.16%4,011,3006兆8445億-1.09%
01/084,2734,2974,2174,250-0.91%5,522,9006兆6995億-3.3%
01/074,2804,3034,2414,289+0.4%3,751,9006兆7609億-2.61%
01/064,2974,3054,2324,272-1.39%4,720,6006兆7341億-3.17%
2019
12/304,3354,3554,3194,332-0.73%2,537,2006兆8287億-2.01%
12/274,3434,3894,3344,364+0.6%2,268,5006兆8792億-1.36%
12/264,3444,3444,3254,338-0.21%2,148,9006兆8382億-2.01%
12/254,3654,3774,3424,347-0.44%1,499,9006兆8524億-1.94%
12/244,3664,4274,3544,366-0.41%2,422,5006兆8823億-1.67%
12/234,3804,4024,3344,384-0.48%3,347,4006兆9107億-1.44%
12/204,4614,4674,3734,405-1.54%5,685,9006兆9438億-1.08%
12/194,4724,4924,4534,474+0.09%3,131,2007兆526億+0.43%
12/184,4804,4804,4484,470+0.04%2,943,2007兆463億+0.43%
12/174,4474,4684,4274,468+0.68%3,461,6007兆431億+0.47%
12/1617:00 2021年満期米ドル建普通社債、2023年満期米ドル建普通社債及び2028年満期米ドル建普通社債のエクスチェンジ・オファーの締め切りと結果に関するお知らせ
12/164,4264,4494,4114,438+0.27%2,524,3006兆9958億-0.05%
12/134,4644,4804,4234,426+0.39%5,372,6006兆9769億-0.2%
12/124,3654,4254,3474,409+0.87%3,614,7006兆9501億-0.54%
12/114,4174,4174,3524,371-1.15%3,218,8006兆8902億-1.29%
12/104,3994,4224,3794,422+1.17%3,508,4006兆9706億0%
12/094,4004,4004,3614,371-0.32%3,207,6006兆8902億-0.97%
12/064,4404,4414,3764,385-1.44%3,897,6006兆9123億-0.32%
12/054,4664,4864,4424,449+0.43%3,374,5007兆132億+1.55%
12/044,4154,4504,4084,430-0.85%4,003,9006兆9832億+1.65%
12/034,4364,5194,4324,468-0.51%4,020,2007兆431億+3.04%
12/024,4854,5104,4734,491+0.81%3,471,8007兆794億+4.2%
11/2917:00 第143期(中間期)事業活動のご報告
11/294,4994,5004,4474,455-0.65%3,135,8007兆226億+3.99%
11/284,4924,5094,4674,484-0.18%2,797,4007兆683億+5.28%
11/274,5104,5174,4884,492+0.38%3,208,0007兆809億+6.14%
11/264,4384,5124,4374,475+1.27%7,312,0007兆541億+6.45%
11/254,4814,5094,4164,419-0.67%3,895,3006兆9659億+5.79%
11/224,4094,4614,3664,449-0.4%4,895,9007兆132億+7.13%
11/2110:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(6⁄6)
11/2110:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(5⁄6)
11/2110:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(4⁄6)
11/2110:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(3⁄6)
11/2110:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(2⁄6)
11/2110:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(1⁄6)
11/214,4954,5004,3974,467-1.37%6,768,7007兆415億+8.19%
11/204,5304,5434,5124,529-0.72%4,303,0007兆1393億+10.44%
11/194,4904,5624,4874,562+1.18%7,828,2007兆1913億+12.12%
11/184,4804,5324,4704,509+1.19%8,366,0007兆1077億+11.77%
11/1520:00 PDT説明会(2019年11月15日コビントン開催)プレゼンテーション資料(4⁄4)
11/1520:00 PDT説明会(2019年11月15日コビントン開催)プレゼンテーション資料(3⁄4)
11/1520:00 PDT説明会(2019年11月15日コビントン開催)プレゼンテーション資料(2⁄4)
11/1520:00 PDT説明会(2019年11月15日コビントン開催)プレゼンテーション資料(1⁄4)
11/154,4344,4814,4074,456+1.92%6,700,9007兆242億+11.34%
11/1420:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(4⁄5)
11/1420:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(3⁄5)
11/1420:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(2⁄5)
11/1420:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(1⁄5)
11/1420:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(5⁄5)
11/1418:00 2021年満期米ドル建普通社債、2023年満期米ドル建普通社債及び2028年満期米ドル建普通社債のエクスチェンジ・オファーの開始に関するお知らせ
11/144,3994,4384,3584,372+0.05%5,840,5006兆8918億+10.1%
11/134,3074,3824,2754,370+1.56%5,678,4006兆8886億+10.89%
11/124,3004,3324,2634,303-0.37%3,946,2006兆7830億+9.99%
11/114,4004,4064,3044,319-1.35%5,328,3006兆8082億+11.11%
11/084,3204,3904,3094,378+2.34%9,588,6006兆9012億+13.27%
11/074,2664,2994,2314,278+1.21%6,494,5006兆7436億+11.41%
11/064,1974,2274,1524,227+0.55%6,623,3006兆6632億+10.74%
11/054,0704,2134,0614,204+5.1%10,314,4006兆6270億+10.66%
11/013,9494,0233,9194,000+1.83%7,995,5006兆3054億+5.65%
10/3115:00 通期連結業績(IFRS)の修正に関するお知らせ
10/3115:00 2020年3月期第2四半期決算短信[IFRS](連結)
10/313,9403,9503,9093,928+1.05%4,576,2006兆1919億+3.92%
10/303,8903,9333,8723,887+0.26%8,450,5006兆1272億+2.99%
10/293,8553,8813,8513,877+1.39%4,178,5006兆1115億+2.84%
10/283,8433,8433,8123,824-0.31%2,474,1006兆279億+1.57%
10/253,8483,8493,8073,836+0.1%2,975,4006兆469億+1.97%
10/243,8453,8593,8293,832+0.55%3,439,1006兆405億+1.91%
10/233,8213,8273,7733,811+0.37%3,436,8006兆74億+1.41%
10/213,7723,8173,7723,797+0.45%2,486,8005兆9854億+1.12%
10/183,8133,8253,7653,780-1.28%4,189,0005兆9586億+0.72%
10/173,8543,8663,8133,829-0.34%4,213,3006兆358億+2.19%
10/163,8493,8713,8203,842+1.48%5,468,1006兆563億+2.7%
10/153,7533,7903,7533,786+1.77%3,862,8005兆9680億+1.37%
10/113,7213,7353,6923,720+0.9%4,158,9005兆8640億-0.35%
10/103,6733,7043,6433,687-0.32%3,726,9005兆8120億-1.26%
10/093,6503,7013,6503,699+0.14%4,024,3005兆8309億-0.94%
10/083,6383,7193,6323,694+2.02%5,598,5005兆8230億-1.02%
10/073,6363,6373,6023,621-0.52%4,265,8005兆7079億-2.87%
10/043,6373,6533,6163,640-1.17%5,093,2005兆7379億-2.23%
10/033,7143,7283,6613,683-2.28%4,035,4005兆8057億-0.89%
10/023,7273,7903,7253,769+0.24%2,935,9005兆9412億+1.67%
10/013,7313,7763,7183,760+1.9%3,903,3005兆9271億+1.79%
09/303,7403,7563,6873,690-2.38%5,708,3005兆8167億+0.11%
09/273,8203,8443,7463,780-2.35%7,071,7005兆9586億+2.72%
09/263,8703,8863,8433,871+0.57%7,871,9006兆1020億+5.48%
09/253,8203,8773,8173,849+1.83%6,546,1006兆673億+5.22%
09/243,7943,8343,7723,780-0.47%7,256,5005兆9586億+3.68%
09/203,7593,8143,7443,798+1.09%7,566,9005兆9870億+4.43%
09/193,7433,7763,7393,757+0.4%4,720,4005兆9223億+3.53%
09/183,7693,7823,7373,742-1.21%4,631,0005兆8987億+3.23%
09/173,7803,7973,7573,788+0.05%4,598,7005兆9712億+4.64%
09/133,7343,8313,7223,786+1.8%8,576,9005兆9680億+4.7%
09/123,7443,7743,7193,719-0.72%5,398,8005兆8624億+2.96%
09/113,6503,7473,6423,746+3.22%6,027,4005兆9050億+3.71%
09/103,6693,6733,6253,629-1.47%5,557,0005兆7205億+0.42%
09/093,6813,7183,6703,683-0.19%4,486,1005兆8057億+1.74%
09/069:30 NATPARA注射剤(副甲状腺ホルモン製剤)の米国における回収について
09/063,7003,7183,6563,690-1.76%5,806,2005兆8167億+1.74%
09/053,7513,7683,7273,756+0.29%5,501,8005兆9207億+3.3%
09/043,7043,7663,6993,745+1.6%6,115,5005兆9034億+3.14%
09/033,6253,6963,6253,686+1.1%3,636,6005兆8104億+1.6%
09/023,5903,6503,5843,646+1.56%3,722,8005兆7473億+0.55%
08/303,5093,5903,4963,590+2.57%5,646,0005兆6591億-1.02%
08/293,4903,5123,4733,500+1.45%6,717,6005兆5172億-3.61%
08/283,4403,4673,4013,450-0.35%3,931,2005兆4384億-5.22%
08/273,4743,4803,4513,462+0.41%3,430,2005兆4573億-5.15%
08/263,4663,4713,4383,448-2.82%5,606,1005兆4352億-5.79%
08/233,5453,5673,5313,548-0.08%2,759,2005兆5929億-3.38%
08/223,5313,5543,4933,551+0.71%4,561,8005兆5976億-3.45%
08/213,5433,5483,5113,526-1.62%4,641,2005兆5582億-4.39%
08/203,5713,5883,5483,584+1.16%3,891,1005兆6496億-3.19%
08/193,5503,5573,5283,543+0.08%3,647,2005兆5850億-4.6%
08/163,5563,5593,5313,540-2.07%5,329,8005兆5803億-5.09%
08/153,5853,6233,5523,615-0.71%4,138,8005兆6985億-3.42%
08/0815:00 (訂正)2020年3月期第1四半期決算短信〔IFRS〕(連結)の一部訂正について